How many employees work at CureDuchenne?
CureDuchenne has approximately 26 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. CureDuchenne’s total headcount has declined 25.6% from 35 employees in 2023 to 26 in 2026.
Is CureDuchenne hiring right now?
No, CureDuchenne is not actively hiring. CureDuchenne had 0 active job postings in 2026, a 0.0% no change from 2025 — see job openings & hiring trends.
About CureDuchenne’s Workforce
CureDuchenne is a Healthcare and Wellness Services company that employs 26 people worldwide as of March 2026. It is the 10th-largest by headcount among its peers. Founded in 2003, the company is headquartered in Newport Beach, California.
CureDuchenne's workforce has declined 25.6% from 2023 to 2026, though it is up 10.7% year over year in 2026. It fell to a low of 22 in 2025 Q3 before recovering. Its workforce is concentrated most in North America (100.0%).
CureDuchenne's functional groups are Finance and Operations (40.1%), Engineering (31.4%), and Sales and Marketing (28.4%), with Sales and Marketing growing fastest (up 16.6%). The average salary is $109,756, highest in North America at a median of $83,000, down 0.5% year over year in 2026.
CureDuchenne's hiring activity held steady in 2026. Overall employee sentiment is negative and broadly stable.
Sourced from Revelio Labs workforce data.
- Headquarters
- Newport Beach, California
- Founded
- 2003
- Industry
- Healthcare and Wellness Services
- Employees
- 26
- YoY
- +10.7% (+1)
As of March 2026
CureDuchenne workforce metrics
Unlock hiring rate, attrition rate, and 12 additional workforce metrics for CureDuchenne. Compare to peers, export the dataset, and access the full quarterly history.
Unlock MetricsCureDuchenne Annual Employee Count (2023-2026)
- CureDuchenne had 26 employees in 2026, a 10.7% increase (+1) from 2025.
- CureDuchenne had 25 employees in 2025, a 4.4% increase (-1) from 2024.
- CureDuchenne had 26 employees in 2024, a 8.0% decline (-9) from 2023.
- CureDuchenne had 35 employees in 2023, a 3.2% decline (-1) from 2022.
CureDuchenne's total workforce has grown from 22 employees in 2025 to 26 in 2026. CureDuchenne's headcount peaked at 36 in 2023 before declining in 2025 and recovering through 2026.
CureDuchenne quarterly employee count
| Year | Qtr | Employees | YoY Change | YoY % |
|---|---|---|---|---|
| 2026 | Q1 | 26 | +1 | +10.7% |
| 2025 | Q4 | 25 | -1 | +4.4% |
| 2025 | Q3 | 22 | -7 | -7.3% |
| 2025 | Q2 | 27 | -2 | +2.7% |
| 2025 | Q1 | 25 | -5 | -4.9% |
| 2024 | Q4 | 26 | -9 | -8.0% |
| 2024 | Q3 | 29 | -7 | -6.4% |
| 2024 | Q2 | 29 | -6 | -10.0% |
| 2024 | Q1 | 30 | -6 | -6.7% |
| 2023 | Q4 | 35 | -1 | -3.2% |
| 2023 | Q3 | 36 | +2 | -3.2% |
| 2023 | Q2 | 35 | +0 | -3.1% |
See CureDuchenne's complete headcount history, including quarterly breakdowns.
Get the DataCureDuchenne Employee Count by Region (2026)
North America accounts for the largest share of CureDuchenne's global workforce with approximately 100% of total employees.
CureDuchenne employees by region
| Region | Employees | % of Total |
|---|---|---|
| North America | 25 | 100.0% |
Drill into city-level data, hiring trends by region, and historic geographic shifts.
Unlock Geographic DataCureDuchenne Employee Count by Department (2026)
CureDuchenne's employee groups are Finance and Operations (40.1%), Engineering (31.4%), and Sales and Marketing (28.4%).
CureDuchenne employees by department
| Department | Employees | % of Total |
|---|---|---|
| Finance and Operations | 10 | 40.1% |
| Engineering | 8 | 31.4% |
| Sales and Marketing | 7 | 28.4% |
Compare CureDuchenne's department mix to industry peers.
See Full DataCureDuchenne Employee Salary by Region (2026)
CureDuchenne's average employee salary is $109,756 globally. Employees in North America receive the highest compensation.
CureDuchenne median employee salary by region (USD)
| Region | Median Salary |
|---|---|
| North America | $83,000 |
Unlock salary by role, level, and city — and compare to CureDuchenne's industry peers.
Unlock Salary DataCureDuchenne Job Openings and Hiring Trends (2023-2026)
- CureDuchenne had 0 active job postings in 2026, a 0% no change from 2025.
- CureDuchenne had 0 active job postings in 2025, a 0% no change from 2024.
- CureDuchenne had 0 active job postings in 2024, a 0% no change from 2023.
- CureDuchenne had 0 active job postings in 2023, a 0% no change from 2022.
- Hiring velocity in 2026: 0 new roles/month, up from 0 in 2025 and 0 in 2024.
CureDuchenne's hiring activity held steady in 2026.
Track new postings per month, role-level demand, and hiring velocity vs. peers.
Unlock Hiring DataCureDuchenne Employee Sentiment (2026)
Revelio Labs tracks employee sentiment across CureDuchenne's workforce based on public professional data. Overall sentiment is negative and has held steady year over year in 2026.
Overall
Unlock the full sentiment breakdown by department, tenure, and trend over time.
Unlock SentimentSimilar Companies
Similar Healthcare and Wellness Services Companies by Employee Count
Frequently Asked Questions About CureDuchenne
- How fast is CureDuchenne growing?
- In 2026, CureDuchenne's headcount grew 10.7% to 26 employees, up from 25 in 2025.
- See the full headcount history
- Where are CureDuchenne employees located?
- Most CureDuchenne employees are based in North America (100.0% of headcount).
- Explore where the workforce is based
- What is the average salary at CureDuchenne?
- The average employee salary at CureDuchenne is approximately $109.8k per year.
- Analyze the salary distribution
- How many new job postings does CureDuchenne open per year?
- In Q1 2026, CureDuchenne opened 0 new job postings. In 2025, CureDuchenne opened 0 new job postings — about 0 per month.
- Track hiring trends by role
- When was CureDuchenne founded and where is it headquartered?
- CureDuchenne was founded in 2003 and is headquartered in Newport Beach, California.
- Compare CureDuchenne to industry peers
Speak with a workforce expert about CureDuchenne.
Book a DemoSee something that doesn't look right? Reach out and our team will review it.